Concordance of dietary sodium intake and concomitant phosphate load: Implications for sodium interventions

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 8, 2016, Pages 689-696

  Humalda, J K ^a   Keyzer, C A ^a,b   Binnenmars, S H ^a   Kwakernaak, A J ^a   Slagman, M C J ^a   Laverman, G D ^b   Bakker, S J L ^a   de Borst, M H ^a   Navis, G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Internal Medicine   (Netherlands)

Author keywords

Dietary counseling; Excretion; Phosphate; Sodium

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; ELECTROLYTE; LISINOPRIL; PHOSPHATE; SODIUM; VITAMIN D; PHOSPHATE INTAKE; SODIUM INTAKE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHATE EXCRETION; PHOSPHATE INTAKE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; ADVERSE EFFECTS; AGED; CASE CONTROL STUDY; COMPLICATION; DIABETIC NEPHROPATHIES; DIET THERAPY; DIETARY REFERENCE INTAKE; FAST FOOD; KIDNEY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; TIME FACTOR; TREATMENT OUTCOME; URINARY EXCRETION; URINE;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIET, SODIUM-RESTRICTED; FAST FOODS; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; NETHERLANDS; PHOSPHATES; PHOSPHORUS, DIETARY; PROSPECTIVE STUDIES; RECOMMENDED DIETARY ALLOWANCES; RENAL ELIMINATION; RENAL INSUFFICIENCY, CHRONIC; SODIUM, DIETARY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84962904495     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2016.04.012     Document Type: Article

References (28)

1. Humalda J.K., Navis G. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens 2014, 23:533-540.
2. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2012, 2:337-414.
3. van Zuilen A.D., Bots M.L., Dulger A., van der Tweel I., van Buren M., Ten Dam M.A., et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int 2012, 82:710-717.
4. Hendriksen M.A., van Raaij J.M., Geleijnse J.M., Wilson-van den Hooven C., Ocke M.C., van der A.D.L. Monitoring salt and iodine intakes in Dutch adults between 2006 and 2010 using 24 h urinary sodium and iodine excretions. Public Health Nutr 2013, 1-8.
5. Slagman M.C., Waanders F., Hemmelder M.H., Woittiez A.J., Janssen W.M., Lambers Heerspink H.J., et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011, 343:d4366.
6. Cozzolino M., Ureña-Torres P., Vervloet M.G., Brandenburg V., Bover J., Goldsmith D., et al. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?. Nephrol Dial Transpl 2014, 29:1815-1820.
7. Scialla J.J., Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 2014, 10:268-278.
8. Kestenbaum B., Sampson J.N., Rudser K.D., Patterson D.J., Seliger S.L., Young B., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005, 16:520-528.
9. Chang A.R., Grams M.E. Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. Am J Kidney Dis 2014, 64:567-573.
10. Zoccali C., Ruggenenti P., Perna A., Leonardis D., Tripepi R., Tripepi G., et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011, 22:1923-1930.
11. Di Iorio B.R., Bellizzi V., Bellasi A., Torraca S., D'Arrigo G., Tripepi G., et al. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients. Nephrol Dial Transpl 2013, 28:632-640.
12. Fardet A., Rock E. The healthy core metabolism: a new paradigm for primary preventive nutrition. J Nutr Health Aging 2015, 1-9.
13. Kalantar-Zadeh K., Gutekunst L., Mehrotra R., Kovesdy C.P., Bross R., Shinaberger C.S., et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:519-530.
14. Cupisti A., Benini O., Ferretti V., Gianfaldoni D., Kalantar-Zadeh K. Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives. J Ren Nutr 2012, 22:533-540.
15. Gonzalez-Parra E., Gracia-Iguacel C., Egido J., Ortiz A. Phosphorus and nutrition in chronic kidney disease. Int J Nephrol 2012, 2012:597605.
16. Carrigan A., Klinger A., Choquette S.S., Luzuriaga-McPherson A., Bell E.K., Darnell B., et al. Contribution of food additives to sodium and phosphorus content of diets rich in processed foods. J Ren Nutr 2014, 24:13-19. 19e1.
17. van den Berg E., Pasch A., Westendorp W.H., Navis G., Brink E.J., Gans R.O., et al. Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients. J Am Soc Nephrol 2014, 25:1303-1312.
18. Kwakernaak A.J., Krikken J.A., Binnenmars S.H., Visser F.W., Hemmelder M.H., Woittiez A.J., et al. Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol 2014, 2:385-395.
19. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
20. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013, 3:1-150.
21. Beaglehole R., Bonita R., Horton R., Adams C., Alleyne G., Asaria P., et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447.
22. Chang A., Batch B.C., McGuire H.L., Vollmer W.M., Svetkey L.P., Tyson C.C., et al. Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study. Am J Kidney Dis 2013, 62:900-907.
23. Williams P.S., Stevens M.E., Fass G., Irons L., Bone J.M. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Q J Med 1991, 81:837-855.
24. Eckberg K., Kramer H., Wolf M., Durazo-Arvizu R., Tayo B., Luke A., et al. Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrol Dial Transpl 2015 Apr, 30:630-635.
25. Gutierrez O.M., Luzuriaga-McPherson A., Lin Y., Gilbert L.C., Ha S.W., Beck GR Impact of phosphorus-based food additives on bone and mineral metabolism. J Clin Endocrinol Metab 2015, 100:4264-4271. jc20152279.
26. de Vries L.V., Dobrowolski L.C., van den Bosch J.J., Riphagen I.J., Krediet C.T., Bemelman F.J., et al. Effects of dietary sodium restriction in kidney transplant recipients treated with renin-angiotensin-aldosterone system blockade: a randomized clinical trial. Am J Kidney Dis 2016, 10.1053/j.ajkd.2015.11.026.
27. Machnik A., Neuhofer W., Jantsch J., Dahlmann A., Tammela T., Machura K., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009, 15:545-552.
28. De Keyzer W., Dofková M., Lillegaard I.T., De Maeyer M., Andersen L.F., Ruprich J., et al. Reporting accuracy of population dietary sodium intake using duplicate 24 h dietary recalls and a salt questionnaire. Br J Nutr 2015, 113:488-497.